Radiation Technology Research Articles

Significance of radiation therapy in frontal glioblastoma patients and exploration of optimal treatment modality: a real-world multiple-center study based on propensity score matching.

Glioblastoma (GBM) exhibits diffuse and invasive growth patterns, with a 5-year overall survival (OS) rate of 5-10%. In addition, approximately 40 percent of GBMs are localized in the frontal lobe, a region closely linked to essential life functions including cognition, so that it cannot be completely eradicated through surgical intervention, leading to very poor prognosis. Postoperative therapy is an essential treatment modality. The aim of this study is to explain the possible role of radiation therapy (RT) in the treatment of frontal GBM, providing more evidence for clinical application. In the study, patient information pertaining to frontal GBM patients was collected from the Surveillance, Epidemiology, and End Results (SEER) database for the period 2000 to 2018 with 9,904 patients deemed appropriate for inclusion in this study. A 1:2 propensity score matching analysis was conducted to balance the non-radiotherapy and radiotherapy group. This study is a retrospective study. Before matching, the median OS, tumor specific survival (TSS) and hazard ratio (HR) were 3 months, 3 months and 4.408 [95% confidence interval (CI): 3.762-4.535, P<0.001] in the non-RT group compared to those of 13 months, 14 months and 2.463 (95% CI: 2.247-2.936, P<0.001) in the RT group. After matching, the median OS, TSS and HR were 3 months, 4 months and 1.433 (95% CI: 1.387-1.692, P<0.001) in the non-RT group compared to those of 8 months, 8 months and 1.427 (95% CI: 1.374-1.682, P<0.001) in the RT group. Radiotherapy is an important local therapy, which can significantly improve the tumor-specific survival and OS of frontal GBM patients. With the arrival of the era of precision radiotherapy, the continuous progress of radiotherapy technology may bring more benefits to frontal GBM patients.

Engineering implementation of permanent magnet uniform spreading system for 3 MeV electron beam accelerator

Electron radiation technology, a significant application of non-power civil nuclear technology, opens up various research opportunities for electron beam accelerators as radiation sources. This paper introduces the engineering implementation of a permanent magnet uniform spreading system for the 3 MeV electron beam accelerator. The system is designed to improve radiation homogeneity, which is a crucial performance parameter in the radiation processing. The paper firstly investigates the collimation of magnets and beam spot in electron beam accelerators and proposes a novel collimation method. In addition, we also address various engineering implementation challenges encountered during the practical application of the uniform spreading system's permanent magnet devices. As a prerequisite for the application of uniform spreading system, a long-term stability experiment is conducted on the permanent magnets in radiation environments. The engineering feasibility of the uniform spreading system is ultimately verified by assessing the radiation homogeneity at the target using radiation dose tablets.

Advancements in Energy Storage and Conversion: The Role of High‐Energy Irradiation Technology

AbstractContemporary challenges have emerged concerning the capability and safety of secondary batteries in the energy storage field. Additionally, catalysts employed in the energy conversion confront issues including inadequate stability and elevated costs. In addition to its traditional use, high‐energy irradiation has found extended application in controlled manipulation of materials for electrochemical energy storage and conversion, due to its unique advantages of no secondary pollution, convenience, and efficiency. This review article shows the recent progress of the application of high‐energy irradiation technology in the field of energy storage and conversion for the first time. The mechanism of material modification via high‐energy irradiation was elaborated, and the application of high‐energy irradiation in tailoring materials for battery components and catalysts was discussed in detail. Finally, challenges for future research of high‐energy irradiation technology in the field of energy storage and conversion were proposed. This review article will provide important significance for subsequent research on high‐energy irradiation technology in the field of energy storage and conversion.

Modification of the Spectral Absorption Characteristics of ZnGeP2 in the THz and IR Wavelength Ranges Due to Diffusion Doping with Impurity Atoms of Mg, Se, Sn, and Pb

This study demonstrates that diffusion doping of ZGP single crystals with impurity atoms (Mg, Se, Sn, Pb) leads to a decrease in the specific conductivity of the samples. Consequently, this results in reduced absorption in the terahertz frequency range (150–1000 μm). It has been shown that doping ZGP samples with selenium (Se) and lead (Pb) atoms reduces absorption in the infrared region from 0.3–0.6 cm−1 to 0.06–0.09 cm−1. Doping with tin (Sn) leads to a decrease in absorption only in the wavelength region near 2.1 μm from 0.2 cm−1 to 0.05 cm−1. The proposed mechanism for the decrease in infrared absorption is a reduction in zinc vacancies due to doping with impurity atoms. This research lays the groundwork for a technology that produces ZGP crystals with minimal absorption within the 2–8 μm wavelength range, eliminating the need for fast electron beam irradiation technology. This advancement will facilitate the fabrication of ZGP crystals with arbitrary apertures.

Customizable Lyophilized Agent for Radiotherapy Imaging and TherapY (CLARITY).

Smart radiotherapy biomaterials (SRBs) include seed and liquid biomaterials designed to be employed as fiducial markers during radiotherapy while also delivering therapeutic drug payloads to enhance treatment outcomes. In this study, we investigate a novel Customizable Lyophilized Agent for Radiotherapy Imaging and TherapY (CLARITY) biomaterial, which can be loaded with immunoadjuvants (anti-CD40 monoclonal antibody or Caflanone (FBL-03G)) at the point of care. The CLARITY biomaterial was investigated in an animal model of pancreatic cancer using C57BL6 mice. Mice were imaged before and at different points of time post-treatment to evaluate the potential of CLARITY biomaterial to provide imaging contrast similar to fiducials. This study also used cadavers to assess CLARITY's potential to provide imaging contrast in humans. Results showed imaging contrast from computed tomography (CT) and magnetic resonance imaging (MRI) modalities for up to 30 days post-treatment, demonstrating potential for use as fiducials. A significant increase in survival (***, p = 0.0006) was observed for mice treated with CLARITY biomaterial loaded with immunoadjuvant for up to 10 weeks post-treatment compared to those without treatment. These initial results demonstrate the potential of CLARITY biomaterial to serve as a smart multifunctional radiotherapy biomaterial and provide the impetus for further development and optimization as a point-of-care technology for combination radiotherapy and immunotherapy.

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer

Optical parameters and gamma shielding quality of sodium-borate glasses: The relative contribution of Bi2O3, SrO, and Li2O

The optical quality and compositional flexibility of borate glasses make them attractive materials for optical applications, nuclear waste containment, transparent radiation shields and many other applications in the nuclear and allied industries. This study presents the physical, optical, and gamma transmission data of the sodium borate glass structure: 75B2O3 – 15Na2O – 9.5x – 0.5Nd2O3; for x = Bi2O3 (BiNd), SrO (SrNd), and Li2O (LiNd). The glasses were prepared using the traditional melt-and-quench technique. The influence of Bi2O3, SrO, and Li2O on the physical attributes, optical constants, and gamma radiation interaction coefficients was probed using standard laboratory procedures and software. The density of BiNd, SrNd, and LiNd was 3.32, 2.43, and 2.24 g/cm3, respectively. The molar volume of the glasses followed the trend: BiNd > SrNd > LiNd. The optical constants of the glasses, such as refractive index, metallization criterion, molar refractivity, molar polarizability, reflectance loss, and optical transmission, showed a wide fluctuation with respect to glass composition. The values of the gamma mass attenuation coefficients for 15 keV–15 MeV photons were in the range 0.0316–45.0225 cm2/g for BiNd, 0.0206–5.4940 cm2/g for SrNd, and 0.0184–3.4603 cm2/g for LiNd. Generally, density has a positive correlation with the gamma absorption prowess of the investigated xNd glasses. A correlation between the optical and shielding parameters was highlighted in this study. The xNd glasses, especially SrNd and BiNd, are preferred as transparent radiation protection barriers, in contrast to some conventional Pb-based glasses, from environmental and public health perspectives. This glass composition is therefore unique and its properties are essentially useful in optical and radiation technologies.

Current understanding of modulated electro-hyperthermia in cancer treatment

Traditional hyperthermia involves increasing the temperature at the tumor site to above 39 ℃, inducing death in cancer cells. Although hyperthermia is an effective cancer treatment, its clinical application has decreased due to potential complications, including damage to surrounding normal tissue. In recent years, modulated electro-hyperthermia (mEHT) has emerged as an effective and safe treatment modality. mEHT selectively heats tumor cells to 42–43 °C, while reducing the average temperature in the treatment area, including the surrounding normal tissue, compared to conventional methods. Additionally, mEHT may be used in combination with systemic chemotherapy and radiation therapy in tumor treatment, providing a synergistic effect to increase efficacy. As chemotherapy and radiation therapy technologies advance, the application of combined mEHT may improve clinical outcomes. In this study, we review and discuss reports on the clinical outcomes of mEHT combined with chemotherapy and/or radiation therapy, which are established anticancer treatments.

Effect of γ-irradiation and antimicrobial agent on properties of poly(L-lactide) active films

Data on irradiation of poly(L-lactide) (PLLA) based active packaging is still limited. Therefore, effect of γ-irradiation on neat PLLA and active packaging with oligohexamethylene guanidine hydrochloride (OHMG·HCl) has been studied. Combined use of irradiation and active packaging technology is promising approach to maintain food safety and prolong shelf life. It has been found that regardless of the OHMG·HCl content PLLA undergoes chain scission during irradiation and this process becomes less pronounced at doses higher than 50 kGy. Slight racemization of PLLA during exposure has been observed using polarimetry and 13C NMR spectroscopy. Mechanical properties of films have been examined. Biocide addition led to a 30% decrease in films elongation at break. Irradiation either caused elongation decrease. Dose of 50 kGy and higher made PLLA active films brittle. Multiple melting behavior of irradiated PLLA has been analyzed by differential scanning calorimetry. Fraction of crystals with higher melting temperature rose with dose. Possible reason for this phenomenon is formation of α′ form with less ordered chain packaging that recrystallizes during heating. The biocide addition has not affected this process. Furthermore, in vitro antimicrobial test has shown efficacy of films with 2 wt.% of OHMG·HCl against gram-negative, gram-positive bacteria and fungi.

Growth of VO2-ZnS thin film cavity for adaptive thermal emission

Low-weight, passive, thermal-adaptive radiation technologies are needed to maintain an operable temperature for spacecraft while they experience various energy fluxes. In this study, we used a thin film coating with the Fabry–Pérot (FP) effect to enhance emissivity contrast (Δε) between VO2 phase-change states. This coating utilizes a hybrid material architecture that combines VO2 with a mid- and long-wave infrared transparent chalcogenide, zinc sulfide (ZnS), as a cavity spacer layer. We simulated the design parameter space to obtain a theoretical maximum Δε of 0.63 and grew prototype devices. Using x-ray diffraction, Raman spectroscopy, and Fourier transform infrared spectroscopy (FTIR), we determined that an intermediate buffer layer of TiO2 is necessary to execute the crystalline growth of monoclinic VO2 on ZnS. Through temperature-dependent FTIR measurements, our fabricated devices demonstrated FP-cavity enhanced adaptive thermal emittance.

Spinal metastases and metastatic spinal cord compression: interpretation for National Institute for Health and Care Excellence (NICE) 2023 guideline

Spine is a common site of metastasis in patients with malignant tumors, and tumor metastasis to the spine can lead to pain, pathological fractures, and nerve compression. In order to optimize the diagnosis and management of patients with spinal metastases and metastatic spinal cord compression (MSCC), the National Institute for Health and Care Excellence (NICE) in the UK proposed the first diagnostic and treatment guidelines for patients with MSCC (or at risk of MSCC) in 2008. In recent years, with the rapid advancement of spinal surgery and radiotherapy technology, the standardized process of MSCC diagnosis and treatment urgently needs to be updated. In 2023, NICE launched new guidelines for spinal metastases and MSCC. Based on a thorough study of the guidelines, this article discusses and interprets pain management, corticosteroid treatment, application of bisphosphonates and denosumab, tools for assessing spinal stability and prognosis, radiation therapy, surgical timing and approach, etc., providing reference for clinical diagnosis and treatment in China.

Ways to improve the results of conservative therapy of malignant tumors of the head and neck organs. Part I. The current state of the issue (review)

The review analyzes the results of conservative therapy of patients with the head and neck cancer. Despite the use of modern radiation and drug technologies, the results of treatment of locally advanced forms of head and neck cancers and relapses are not satisfactory. The most effective is the simultaneous use of modified radiation and chemotherapy regimens. However, the implementation of the treatment plan with this method is limited to the development of pronounced early and late toxic effects on normal tissues and organs. The radiosensitizing effect of targeted therapy was also analyzed.

Gamma, electron beam and X-ray irradiation effects on polymers in an advanced bone cement mixer device

The medical device industry has been investigating ways to increase the use of alternatives to cobalt-60 gamma radiation and ethylene-oxide gas sterilization, such as electron beam (E-beam) and X-ray radiation, due to regulatory and market pressures. One impediment to switching to E-beam or X-ray technology for sterilization is the lack of data on the effects of these radiation sources on medical device polymers. To provide such data this work considers irradiation and testing of a common single-use medical bone cement mixing system, the Stryker Advanced Cement Mixer (ACM®), that is composed of seven polymer materials. The ACM® devices considered here were processed to sterilization-relevant doses (15, 25, 50, and 70 kGy) using three radiation technologies: gamma, E-beam, and X-ray. The system and its polymer components were tested for product functionality, as well as mechanical and visual properties to determine how exposure effects may be influenced by radiation technology and dose level. We found that although there were instances of statistically significant differences in effects between the gamma-irradiated products and those irradiated with E-beam and X-ray, those effects were negligible in terms of retained functionality of the product and retained mechanical properties of the polymer components. Overall, results of this study demonstrate that, for of the effects studied, E-beam and X-ray are viable alternatives to cobalt-60 gamma radiation for sterilization of the polymer-based device investigated.

Laser-Generated Au nanoparticles as lithophilic sites in self-supported film host for anode-free lithium metal battery

Anode-free lithium metal batteries (AFLMBs) are considered to have greater application potential than traditional LMBs because of their higher energy density and safety. Unfortunately, their poor cycling performances originated from the unsatisfactory reversibility of Li plating/stripping remains a big challenge. A rational designed host for lithium deposition is an effective solving strategy. Herein, pure Au nanoparticles (NPs) without any impurities are prepared by a liquid-phase laser irradiation technology to construct and develop a self-supported Au/reduced graphene oxide (Au/rGO) film as lithium deposition host for AFLMBs. The densely and uniformly distributed Au NPs provide abundant lithiophilic sites that significantly reduce the nucleation barrier of lithium. Attributed to the precise regulation of Au sites towards lithium nucleation/growth, dendrites-free anode and improved electrochemical performance are obtained by using the Au/rGO film host. It keeps stable for 30 min of lithiation at 6 mA cm−2 without dendrite formation. Additionally, the Li||Au/rGO half-cell shows an overpotential close to 0 mV and maintains a Coulombic efficiency exceeding 97 % after 500 cycles at 1 mA cm−2. Moreover, a symmetric Au/rGO-Li cell can operate for 700 h without short-circuit. When paired with LiFePO4 (LFP) to assemble a full battery, the Au/rGO-Li achieves 96 % capacity retention rate after 100 cycles. This work not only develops an efficient host for lithium, but also provides a unique strategy to the safety concerns associated with LMBs’ anodes.

Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society

AimsSymptomatic radiation cardiotoxicity affects up to 30% patients with lung cancer and several heart substructure doses are associated with reduced overall survival. A greater focus on minimising cardiotoxicity is now possible due to advancements in radiotherapy technology and the new discipline of cardio-oncology, but uptake of emerging data has not been ascertained. A global cross-sectional analysis of Radiation Oncologists who treat lung cancer was therefore conducted by the International Cardio-Oncology Society in order to establish the impact of recently published literature and guidelines on practice. Materials and methodsA bespoke questionnaire was designed following an extensive review of the literature and from recurring relevant themes presented at Radiation Oncology and Cardio-Oncology research meetings. Six question domains were retained following consensus discussions among the investigators, comprising 55 multiple choice stems: guidelines, cardiovascular assessment, cardiology investigations, radiotherapy planning strategies, primary prevention prescribing and local cardio-oncology service access. An invitation was sent to all Radiation Oncologists registered with ICOS and to Radiation Oncology colleagues of the investigators. ResultsIn total 118 participants were recruited and 92% were consultant physicians. The ICOS 2021 expert consensus statement was rated as the most useful position paper, followed by the joint ESC–ESTRO 2022 guideline. The majority (80%) of participants indicated that a detailed cardiovascular history was advisable. Although 69% of respondents deemed the availability of cardiac substructure auto-segmentation to be very/quite important, it was implemented by only a few, with the most common being the left anterior descending coronary artery V15. A distinct cardio-oncology service was available to 39% participants, while the remainder utilised general cardiology services. ConclusionThe uptake of recent guidelines on cardiovascular optimisation is good, but access to cardiology investigations and consultations, and auto-segmentation, represent barriers to modifying radiotherapy practices in lung cancer to reduce the risk of radiation cardiotoxicity.

THEORETICAL INVESTIGATION FOR YTTERBIUM EFFECT ON RADIATION SHIELDING CHARACTERISTICS OF 50Bi2O3-15Li2O-15PbO-(20-X)B2O3-Yb2O3 BORATE GLASSES

As the nuclear industry has developed and radiation technologies have become more widely used, the dose of radiation from both synthetically produced sources and radioisotopes has increased, as has the number of people being irradiated. It is of the utmost importance to utilise appropriate shielding materials in order to reduce the negative effects of radiation sources. Doped glasses are among the most significant candidate materials in the field of radiation shielding. To this end, it was aimed to investigate the charged particle, gamma-ray and neutron shielding characteristics of ytterbium doped glasses with composition of 50Bi2O3-15Li2O-15PbO-(20-x)B2O3-Yb2O3 (where x = 0.5, 1.0, 1.5, 2.0 and 2.5). In this regard, the radiation shielding parameters were estimated by using Phy-X/PSD, PAGEX, ESTAR, and SRIM codes. Furthermore, the results were compared comprehensively and comparatively. Charged particle (alpha, proton and electron), gamma ray and neutron shielding efficiencies were found to be proportional to ytterbium content. The glasses with the increasing amount of ytterbium exhibited higher shielding performances. It can be said that all the studied glasses and particularly Yb2.5 sample could be used as shielding materials in many radiation related applications.

Room-temperature flexible phase change material with high emissivity and high enthalpy for building energy saving

Summer heatwave events become more and more frequent, building cooling load continues to rise, and the traditional cooling method using air conditioning consumes a lot of energy. New technologies and materials with high efficiency, energy saving and low cost are urgently needed to solve the problem of high energy consumption in buildings. In this paper, by combining phase change storage technology with passive cooling technology of sky radiation, a new type of high-emission flexible composite phase change material (CPCM) was prepared using polypropylene hollow fiber (PP hollow fiber), Styrene-Ethylene-Butylene-Styrene (SEBS) and paraffin wax (PA). The prepared CPCM with excellent thermophysical properties, including a latent heat of 175.19 J/g, room temperature flexibility, the contact angle of the hydrophobic test of 129.15°, and the infrared emissivity of the atmospheric window of 0.942. The cooling experiment results show that the maximum temperature difference between CPCM and the environment is 2.6 °C lower than the ambient temperature. In addition, the simulation results show that the external surface temperature of the CPCM roof can be reduced by 23.15 K at the highest compared with a common roof, and the maximum energy saving can reach 13.24 W/m2. Compared with the high emissivity roof without CPCM, the external surface temperature is further reduced by 0.47K, the delay time is 50min, and the maximum energy saving can reach 0.76 W/m2. It's worth getting excited that CPCM can delay the opening time of air conditioning for 10 days. In addition, the application efficiency of cities in typical climate regions is simulated, and outstanding energy-saving efficiency is obtained, among which the maximum saving energy in Guangzhou is as high as 20.16 W/m2. The successful preparation of the novel CPCM material provides a new direction for the development of radiation-cooling technology.

The Latest Developments and Applications in Radiation Therapy Equipment and Technology

This paper reviews the latest technological developments in contemporary radiation therapy equipment and their significance in clinical applications. It begins with an introduction to the basic principles and historical evolution of radiation therapy, followed by a detailed analysis of common types of radiation therapy equipment, including linear accelerators, Gamma Knives, proton therapy equipment, and heavy ion therapy equipment. For each type, the paper conducts an in-depth comparative analysis of their technical characteristics, covering aspects such as performance, accuracy, therapeutic efficacy, safety, side effects, cost, and maintenance. The paper then explores the latest trends in radiation therapy technology development, such as image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), and adaptive radiation therapy (ART), highlighting their clinical applications and potential through case studies. Finally, the paper looks forward to future development directions in radiation therapy technology, including the research and development of new equipment and technologies, trends in personalized treatment, and the prospects for artificial intelligence in radiation therapy. The aim of this paper is to provide comprehensive references and guidance for research and clinical practice in radiation therapy equipment.

Palliative Thoracic Radiotherapy in the Era of Modern Cancer Care for NSCLC.

Palliative thoracic radiotherapy provides rapid and effective symptom relief in approximately two-thirds of NSCLC patients treated. In patients with poor performance status, the degree of palliation appears unrelated to the radiation dose or fractionation schedule. Conversely, in patients with good performance status, higher radiation doses administered over longer periods have shown modest survival benefits. These findings stem from studies conducted before the advent of immunotherapy and targeted therapy in clinical practice. Currently, there are no large prospective studies specifically dedicated to palliative radiotherapy conducted in this new treatment era. Modern radiotherapy technologies are now widely available and are increasingly used for palliative purposes in selected patients, reflecting the expanded array of therapeutic options for disseminated NSCLC and improved prognosis. Some traditional tenets of palliative thoracic radiotherapy, such as the improvement of overall survival with a protracted radiation schedule and the use of simple, cost-effective radiation techniques for palliative purposes, may no longer hold true for patients receiving immunotherapy or targeted therapy. The application of IMRT or SBRT in the context of palliative radiotherapy for NSCLC is not yet sufficiently explored, and this is addressed in this review. Moreover, new risks associated with combining palliative radiotherapy with these systemic treatments are being explored and are discussed within the context of palliative care. The optimal timing, doses, fractionation schedules, and treatment volumes for radiotherapy combined with immunotherapy or targeted therapy are currently subjects of investigation. In emergencies, radiotherapy should be used as a life-saving measure without delay. However, for other indications of palliative thoracic radiotherapy, decisions regarding doses, timing relative to systemic treatments, and treatment volumes should be made in a multidisciplinary context, considering the patient's prognosis, anticipated outcomes, and access to potentially effective treatments. We still lack robust data from prospective studies on this matter. This review examines and discusses available evidence on the use of palliative thoracic radiotherapy within the framework of modern treatment strategies for NSCLC.

Global hotspots and research trends of radiation-induced skin injury: a bibliometric analysis from 2004 to 2023.

Radiation therapy has become an important treatment for many malignant tumours after surgery and for palliative tumour care. Although modern radiotherapy technology is constantly improving, radiation damage to normal tissues is often difficult to avoid, and radiation-induced skin injury (RSI) is a common complication, manifested as skin erythema, peeling, ulceration, and even bone and deep organ damage, seriously affect the quality of life for patients. Basic research and clinical trials related to RSI have achieved certain results, while no researchers have conducted comprehensive bibliometric studies. A comprehensive bibliometric analysis of publications on RSI published between 2004 and 2023 was conducted to identify current hotspots and future directions in this area of study. RSI-related publications published between January 1, 2004, and December 31, 2023, were retrieved from the Web of Science Core Collection (WoSCC) database for analysis using VOSviewer and CiteSpace analytics. A total of 1009 publications on RSI from 2004 to 2023 were included in the WoSCC database. The United States had the highest productivity with 299 papers, accounting for 29.63% of the total production, followed by China with 193 papers (19.13%) and Japan with 111 papers (11.00%). In terms of research institutions and journals, the University of Toronto and Journal of Supportive Care in Cancer published the highest number of papers. Professor Edward Chow published the most articles, while Professor Shuyu Zhang was the most cited. The top ten most-cited papers focused on the pathogenesis, prevention, and management of RSI. Keyword co-occurrence analysis and the top 25 keywords with the strongest citation bursts suggest that current research focuses on the pathogenesis, prevention, and treatment management of RSI. This study conducted a systematic bibliometric analysis of RSI publications from 2004 to 2023; identified the trends in RSI publications, major research countries, major research institutions, major research journals, major research authors, and major research keywords; and revealed the future development direction and research hotspots of this field. This study provides a valuable reference for future RSI research.